Alpha Tau Medical (DRTS) Competitors $3.20 -0.22 (-6.43%) Closing price 04:00 PM EasternExtended Trading$3.22 +0.02 (+0.63%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRTS vs. BLFS, PLSE, INMD, IRMD, KMTS, SIBN, BBNX, EMBC, AXGN, and ZIMVShould you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include BioLife Solutions (BLFS), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), Kestra Medical Technologies (KMTS), SiBone (SIBN), Beta Bionics (BBNX), Embecta (EMBC), AxoGen (AXGN), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry. Alpha Tau Medical vs. Its Competitors BioLife Solutions Pulse Biosciences InMode iRadimed Kestra Medical Technologies SiBone Beta Bionics Embecta AxoGen ZimVie BioLife Solutions (NASDAQ:BLFS) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership. Does the media favor BLFS or DRTS? In the previous week, BioLife Solutions had 9 more articles in the media than Alpha Tau Medical. MarketBeat recorded 14 mentions for BioLife Solutions and 5 mentions for Alpha Tau Medical. BioLife Solutions' average media sentiment score of 0.55 beat Alpha Tau Medical's score of -0.07 indicating that BioLife Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 5 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Tau Medical 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, BLFS or DRTS? BioLife Solutions has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Which has stronger earnings and valuation, BLFS or DRTS? BioLife Solutions has higher revenue and earnings than Alpha Tau Medical. BioLife Solutions is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$82.25M14.75-$20.18M-$0.12-211.00Alpha Tau MedicalN/AN/A-$31.75M-$0.48-6.67 Do institutionals & insiders hold more shares of BLFS or DRTS? 93.2% of BioLife Solutions shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts recommend BLFS or DRTS? BioLife Solutions presently has a consensus price target of $31.29, suggesting a potential upside of 23.56%. Alpha Tau Medical has a consensus price target of $8.00, suggesting a potential upside of 150.00%. Given Alpha Tau Medical's higher probable upside, analysts plainly believe Alpha Tau Medical is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is BLFS or DRTS more profitable? Alpha Tau Medical has a net margin of 0.00% compared to BioLife Solutions' net margin of -5.39%. BioLife Solutions' return on equity of 0.16% beat Alpha Tau Medical's return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-5.39% 0.16% 0.14% Alpha Tau Medical N/A -51.21%-38.18% SummaryBioLife Solutions beats Alpha Tau Medical on 10 of the 14 factors compared between the two stocks. Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRTS vs. The Competition Export to ExcelMetricAlpha Tau MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$290.08M$7.07B$5.62B$9.84BDividend YieldN/A1.30%4.61%4.07%P/E Ratio-6.6725.4830.2925.74Price / SalesN/A73.48463.41115.83Price / CashN/A21.9738.2159.48Price / Book3.145.388.826.15Net Income-$31.75M$176.29M$3.25B$265.06M7 Day Performance-2.14%3.76%4.05%2.80%1 Month Performance-0.93%-0.66%4.32%1.68%1 Year Performance51.66%12.98%36.25%29.59% Alpha Tau Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRTSAlpha Tau Medical2.5701 of 5 stars$3.20-6.4%$8.00+150.0%+62.9%$290.08MN/A-6.6780Earnings ReportBLFSBioLife Solutions2.3116 of 5 stars$20.89+0.4%$31.00+48.4%-3.2%$995.21M$82.25M-72.03440News CoverageEarnings ReportInsider TradePLSEPulse Biosciences3.8299 of 5 stars$15.07+2.2%$22.00+46.0%-0.7%$992.29M$700K0.00140News CoverageEarnings ReportINMDInMode2.7881 of 5 stars$14.07+2.4%$18.04+28.2%-8.7%$868.49M$401.56M5.70480Positive NewsIRMDiRadimed4.517 of 5 stars$70.69+6.8%$72.00+1.9%+61.4%$841.36M$73.24M43.64110High Trading VolumeKMTSKestra Medical Technologies1.3634 of 5 stars$15.49+0.7%$27.33+76.5%N/A$789.75M$59.82M0.00300SIBNSiBone4.3712 of 5 stars$17.90+2.9%$22.50+25.7%+12.4%$741.07M$167.18M-27.97350Analyst ForecastInsider TradeHigh Trading VolumeBBNXBeta Bionics2.6568 of 5 stars$16.42+0.1%$22.56+37.4%N/A$712.91M$65.12M0.00294Positive NewsEMBCEmbecta4.7427 of 5 stars$9.79-1.7%$19.00+94.1%-5.9%$582.09M$1.08B10.882,100Earnings ReportAXGNAxoGen2.9077 of 5 stars$12.55-0.9%$24.50+95.2%+31.1%$577.04M$187.34M-83.66450Short Interest ↑ZIMVZimVie0.4494 of 5 stars$18.77+0.1%$17.75-5.4%+11.5%$529.05M$449.75M-26.811,770Short Interest ↑ Related Companies and Tools Related Companies BLFS Alternatives PLSE Alternatives INMD Alternatives IRMD Alternatives KMTS Alternatives SIBN Alternatives BBNX Alternatives EMBC Alternatives AXGN Alternatives ZIMV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRTS) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access